Strategies to Counteract Mono- and Polymicrobial Biofilm-Related Infections
A special issue of Antibiotics (ISSN 2079-6382). This special issue belongs to the section "Antibiofilm Strategies".
Deadline for manuscript submissions: 30 August 2025 | Viewed by 589
Special Issue Editor
Interests: biofilm formation; cystic fibrosis; lung infections; antibiotic resistance; antimicrobial compounds; Pseudomonas aeruginosa
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Biofilms are functional consortia of microbial cells embedded into a self-produced complex matrix composed of extracellular polymeric substances, including proteins, extracellular DNA (eDNA), and exopolysaccharides. Microbial infections are mainly caused by biofilms or polymicrobial biofilms involving various bacteria, fungi, or viruses. The infections associated with biofilms are becoming increasingly difficult to control due to their chronicity and the emergence of antibiotic resistance.
This Special Issue is a call to action for innovative solutions in the field of biofilm control and treatment. We are interested in all aspects, from preventing biofilm formation to developing novel anti-biofilm agents. We also welcome the introduction of new diagnostic tools and improved strategies and therapies that could revolutionize the way we control and treat biofilm-based infections.
Prof. Dr. Giovanni Di Bonaventura
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- antimicrobials
- anti-biofilm
- biofilm control
- biofilm-associated infections
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.